Health Catalyst, Inc. (HCAT) · 10+ Years of Financial statements

Income Statement	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	73	113	155	189	242	276	296
+ Sales & Services Revenue	73	113	155	189	242	276	296
- Cost of Revenue	44	60	75	98	124	143	164
+ Cost of Goods & Services	44	60	75	98	124	143	164
Gross Profit	29	53	80	91	118	133	132
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	75	113	134	187	261	273	259
+ Selling, General & Admin	41	67	79	115	161	149	144
+ Research & Development	28	39	46	54	63	76	73
+ Other Operating Expense	6	7	9	19	38	48	42
Operating Income (Loss)	-46	-60	-55	-96	-144	-140	-127
- Non-Operating (Income) Loss	1	2	5	20	16	2	-9
+ Interest Expense, Net	1	1	1	9	16	2	-9
+ Interest Expense	1	2	3	12	17	7	7
- Interest Income	1	1	3	2	1	6	16
+ Other Non-Op (Income) Loss	1	1	4	11	- -	- -	- -
Pretax Income	-47	-62	-60	-116	-160	-142	-118
- Income Tax Expense (Benefit)	- -	- -	- -	-1	-7	-4	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-47	-62	-60	-115	-153	-137	-118
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-47	-62	-60	-115	-153	-137	-118
- Minority Interest	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-47	-62	-60	-115	-153	-137	-118
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-47	-62	-60	-115	-153	-137	-118
Basic Weighted Avg Shares	28	28	19	40	47	54	56
Basic EPS, GAAP	-1.69	-2.23	-3.21	-2.91	-3.23	-2.56	-2.09
Basic EPS from Cont Ops	-1.69	-2.23	-3.21	-2.91	-3.23	-2.56	-2.09
Diluted Weighted Avg Shares	28	28	19	40	47	54	56
Diluted EPS, GAAP	-1.69	-2.23	-3.21	-2.91	-3.23	-2.56	-2.09
Diluted EPS from Cont Ops	-1.69	-2.23	-3.21	-2.91	-3.23	-2.56	-2.09
EBITDA	-40	-53	-46	-77	-106	-92	-85
EBITDA Margin (%)	-54.25	-46.8	-29.46	-40.99	-43.87	-33.2	-28.61
EBITA	-46	-60	-55	-96	-144	-140	-127
EBIT	-46	-60	-55	-96	-144	-140	-127
Gross Margin (%)	40.28	46.83	51.37	48.06	48.6	48.21	44.55
Operating Margin (%)	-62.31	-53.38	-35.41	-50.9	-59.38	-50.68	-42.88
Profit Margin (%)	-64.36	-55.06	-38.79	-60.91	-63.33	-49.74	-39.92
Sales per Employee	- -	- -	172,157	188,845	201,605	230,197	227,645
Dividend per Share	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	6	7	9	19	38	48	42

Balance Sheet	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	71	67	264	330	508	428	393
+ Cash, Cash Equivalents & STI	51	33	228	271	445	363	318
+ Cash & Cash Equivalents	23	28	18	92	193	116	106
+ ST Investments	28	5	210	179	252	247	211
+ Accounts & Notes Receiv	17	28	28	48	49	48	60
+ Accounts Receivable, Net	17	28	28	48	49	48	60
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	3	6	8	11	15	16	15
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	39	44	38	248	324	324	308
+ Property, Plant & Equip, Net	5	11	8	38	44	43	40
+ Property, Plant & Equip	11	19	18	48	56	60	67
- Accumulated Depreciation	6	8	10	10	11	17	27
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	34	33	30	210	279	282	269
+ Total Intangible Assets	33	32	29	207	275	278	264
+ Goodwill	4	4	4	108	170	186	191
+ Other Intangible Assets	30	28	26	99	105	92	73
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	1	1	4	4	4	5
Total Assets	110	111	302	578	832	752	702
+ Payables & Accruals	17	7	10	14	11	12	18
+ Accounts Payable	1	2	4	5	5	4	7
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	16	5	7	9	6	8	12
+ ST Debt	2	4	3	3	3	3	3
+ ST Borrowings	- -	1	- -	- -	- -	- -	- -
+ ST Finance Leases	2	3	3	3	3	3	3
+ Other ST Liabilities	12	31	35	71	79	67	67
+ Deferred Revenue	11	25	31	47	57	55	56
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	1	6	4	24	22	12	12
Total Current Liabilities	31	42	48	88	93	83	89
+ LT Debt	10	23	50	193	201	245	246
+ LT Borrowings	10	19	48	169	181	227	228
+ LT Finance Leases	1	4	2	24	20	18	18
+ Other LT Liabilities	328	421	4	21	16	- -	- -
+ Accrued Liabilities	- -	7	1	2	1	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	328	414	2	19	15	- -	- -
Total Noncurrent Liabilities	339	444	53	214	217	245	246
Total Liabilities	370	486	102	302	310	327	335
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	- -	- -	811	1,002	2,802	1,425	1,484
+ Common Stock	- -	- -	- -	- -	1,401	1,425	1,484
+ Additional Paid in Capital	- -	- -	811	1,002	1,401	- -	- -
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-259	-375	-611	-726	-879	-999	-1,117
+ Other Equity	- -	- -	- -	- -	- -	-1	- -
Equity Before Minority Interest	-259	-375	201	276	522	425	367
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
Total Equity	-259	-375	201	276	522	425	367
Total Liabilities & Equity	110	111	302	578	832	752	702
Shares Outstanding	28	28	37	43	53	55	58
Capital Leases - Total	3	7	4	26	24	21	21
Net Debt	-13	-8	30	77	-12	110	122
Net Debt to Equity	5.15	2.22	15.04	27.9	-2.35	25.93	33.18
Tangible Common Equity Ratio	-380.13	-515.04	62.76	18.69	44.38	30.97	23.5
Current Ratio	2.32	1.6	5.48	3.75	5.46	5.18	4.42
Cash Conversion Cycle	- -	64.48	51.93	56.66	58.53	52.3	54.46
Number of Employees	- -	- -	900	1,000	1,200	1,200	1,300

Cash Flow Statement	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-47	-62	-60	-115	-153	-137	-118
+ Depreciation & Amortization	6	7	9	19	38	48	42
+ Non-Cash Items	4	8	23	74	88	68	57
+ Stock-Based Compensation	4	4	18	38	65	72	56
+ Deferred Income Taxes	- -	- -	- -	-1	-7	-5	- -
+ Asset Impairment Charge	- -	- -	- -	- -	2	5	4
+ Other Non-Cash Adj	- -	4	6	37	28	-5	-3
+ Chg in Non-Cash Work Cap	- -	7	-5	-4	5	-14	-14
+ (Inc) Dec in Accts Receiv	4	-4	- -	-16	- -	1	-14
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-1	-1	-2	-4	-4	- -	- -
+ Inc (Dec) in Accts Payable	-6	5	- -	8	5	-5	5
+ Inc (Dec) in Other	2	7	-3	8	4	-10	-5
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-37	-40	-32	-26	-23	-35	-33
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-3	-2	-4	-9	-12	-4	-2
+ Acq of Fixed Prod Assets	-2	-2	-2	-8	-10	-2	-1
+ Acq of Intangible Assets	-1	- -	-2	-1	-1	-2	-1
+ Net Change in LT Investment	26	24	-205	30	-74	6	46
+ Dec in LT Investment	72	38	51	219	187	315	337
+ Inc in LT Investment	-46	-14	-256	-190	-261	-309	-291
+ Net Cash From Acq & Div	- -	- -	- -	-102	-47	-28	-11
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	-102	-47	-28	-11
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	-1	-7	-13	-12
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	22	21	-210	-83	-140	-39	20
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	20	10	4	108	- -	- -	- -
+ Cash From Debt	20	10	47	222	- -	- -	- -
+ Repayments of Debt	- -	- -	-44	-114	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	-9	195	- -	245	-8	-2
+ Increase in Capital Stock	- -	- -	195	- -	245	- -	- -
+ Decrease in Capital Stock	- -	-9	- -	- -	- -	-8	-2
+ Other Financing Activities	5	23	33	74	19	6	5
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	25	24	231	183	264	-3	3
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	10	5	-10	74	101	-77	-10
Capital Expenditures	-3	-2	-4	-9	-12	-4	-2
EBITDA	-40	-53	-46	-77	-106	-92	-85
EBITDA Margin (%)	-54.25	-46.8	-29.46	-40.99	-43.87	-33.2	-28.61
Net Cash Paid for Acquisitions	- -	- -	- -	102	47	28	11
Free Cash Flow	-40	-43	-36	-35	-35	-40	-35
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-32	-31	74	-34	-37	-34
Free Cash Flow per Basic Share	-1.45	-1.53	-1.93	-0.89	-0.74	-0.74	-0.63
Price/Free Cash Flow	- -	- -	-22.57	-99.93	-170.9	-17.96	-17.46
Cash Flow to Net Income	0.78	0.65	0.54	0.23	0.15	0.26	0.28

Health Catalyst, Inc.

HCAT US

6.42

6.42